PTC Therapeutics may reeling from the failure of its amyotrophic lateral sclerosis (ALS) drug utreloxastat yesterday, but the ...
PTC Therapeutics (PTCT) announced that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150M ...
Pharmaceuticals announced that the U.S. Food and Drug Administration or FDA, has accepted for review the Company’s supplemental ...
It's been 17 long years since we last cruised around the galaxy aboard the SSV Normandy, but we're finally back thanks to ...
London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License ...
The Centre on Monday asked all states to review and update fire prevention and response plans of all health facilities, including training of healthcare staff on safety protocols and ensuring regular ...